Announcements Trials
Browse Landscape

Status

Completed 7Recruiting 5Unknown 3Active not recruiting 3Not yet recruiting 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Gastrointestinal 7Thoracic 5Gynecologic 4Head & Neck 3Lymphoid 2Endocrine 2Tumor-Agnostic 1Myeloid 1Dermatologic 1Classical hematology 1

Conditions

Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Non-Hodgkin 1

Interventions

Cyclophosphamide 30Rituximab 23zanubrutinib 18fludarabine 14Vincristine 14venetoclax 13Prednisone 13blinatumomab 12Magnetic Resonance Spectroscopy 12Specimen Handling 11Doxorubicin 11obinutuzumab 10Bendamustine Hydrochloride 10Lenalidomide 9Dexamethasone 8polatuzumab vedotin 7glofitamab 7Methotrexate 7Radiotherapy 6Prednisolone 6N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 6Cytarabine 6Biopsy 6pirtobrutinib 5pegaspargase 5Immunotherapy, Adoptive 5tislelizumab 4tafasitamab 4selinexor 4orelabrutinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Observation × Lymphoid × Clear all
NCT07310186 2025-12-30

Treatment and Outcomes of DLBCL After Progression on Polatuzumab Vedotin-based Combination Therapy

Peking Union Medical College Hospital

Not yet recruiting
200 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT05746858 2023-02-28

MIMOSA

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Not yet recruiting
300 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡